Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 31 results for "cadila healthcare click"

Accumulate Cadila Healthcare; target of Rs 1220: KRChoksey

KRChoksey`s research report on Cadila Healthcare Cadila Healthcare, net sales grew by 25.7% YoY to Rs2020crs driven by improved traction in US business & Emerging markets. EBIDTA excluding forex impact grew by 42.3% YoY to Rs371crs & EBITDA ..., 1 month ago
Cadila Healthcare: Updates on outcome of AGM, 1 month ago
Hold Cadila Healthcare; target of Rs 1300: Sharekhan, 1 month ago

1 images for "cadila healthcare click", 2 months ago

Cadila Healthcar - Zydus receives tentative approval for Gli...

The page you are looking for might have been removed, had its name changed, or is temporarily unavailable. Please try the following: Make sure that the Web site address displayed in the address bar of your browser is spelled and formatted ...
 SBICAP Securities3 days ago Zydus receives tentative approval for Glipizide ER tablets  Moneycontrol.com3 days ago Cadila Healthcar - Zydus receives final approval for Telmisa...  SBICAP Securities2 weeks ago Zydus receives final approval for Acyclovir Tablets  Moneycontrol.com1 month ago

More price controls in India: Derogative step for pharma

Motilal Oswal has come out with its report on healthcare sector. Among MNCs, Sanofi India is likely to be the most impacted, while Indian companies are expected to see a PAT impact of 1-4%, says report. New directive expands span of price control ...
 Moneycontrol.com2 months ago

India: Government caps prices of 36 more drugs

A senior official of India's drug pricing authority said Friday that the government has capped the prices of a further 36 drugs, as reported in Business Standard. The medicines, including those used to treat infections and diabetes, join the 348 ...
 FirstWord Pharma7 hours ago

Gilead (GILD) Slips on Generic Sovaldi Licensing Deals - Analyst Blog

Shares of Gilead Sciences ( GILD ) declined 2.58% to close the trading session on Sep 15 at $100.99 following its licensing deals on generic Sovaldi (sofosbuvir) with seven India-based generic players including companies like Mylan ( MYL ), Cadila ...
 Zacks.com2 days ago Gilead Sciences enters deals with seven Indian drugmakers for Sovaldi generics  FirstWord Pharma4 days ago

Hitachi, Gilead, Amazon, Facebook: Intellectual Property

The U.S. Court of Appeals for the Federal Circuit rejected Hitachi Ltd. (6501)'s bid for a new trial in a case involving TPV Technology Ltd. (903) and its Top Victory Electronics Taiwan unit. In a trial last year, Tokyo-based Hitachi sought as ...
 BusinessWeek3 days ago

Cardiovascular Pharmaceuticals Market in India 2014, New Report Launched

[September 15, 2014] (ReleaseWire Via Acquire Media NewsEdge) Market Research Reports, Inc. has announced the addition of Cardiovascular Pharmaceuticals Market in India 2014 research report to their website ...
 TMC Net4 days ago New Report Available: Contract Research and Manufacturing (CRAMS) Service Market in India 2014-2018  TMC Net1 week ago

Daily Market Strategy - Lower opening, yet on the road to new highs

No matter how far you have gone on the wrong road, you can still turn around. - Anonymous Though the indices are back to hitting new highs, it remains in a range which could perhaps unnerve existing investors and prevent new ones from coming.
 India Infoline4 days ago

Treatments for Syndromes of Dementia and Movement Disorders - Global Industry Analysis and Forecast to 2020

(ReleaseWire Via Acquire Media NewsEdge) Persistence Market Research pressents new released report on " "New York, NY -- (ReleaseWire) -- 09/12/2014 -- Dementia is one of the serious brain disorders which lead to memory loss, language and thinking ...
 TMC Net1 week ago

Biocon : Market Report, "Biocon Limited - Product Pipeline Review - 2014", published

] Biocon Limited - Product Pipeline Review - 2014 Summary Global Markets Direct's, ' Biocon Limited - Product Pipeline Review - 2014', provides an overview of the Biocon Limited's pharmaceutical research and development focus. This report ...
 4 Traders3 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - cadila healthcare click
Get updated on latest news & your favorite topics right in your inbox!
More     Less